ERRATUM

In the Pharmacology Toxicology Section of the Advisory Committee Briefing Document for NDA 21,318 (ForteoTM), the 2nd paragraph on page 5 reads:

"The incidence and degree of tunneling (intratrabecular remodeling) was dose-dependently and reversibly increased in vertebrae and iliac crest by LY333334. The incidence of woven in iliac crest biopsies bone was also increased at 15 months."

The last sentence in this paragraph should be deleted and the paragraph should read:

"The incidence and degree of tunneling (intratrabecular remodeling) was dose-dependently and reversibly increased in vertebrae and iliac crest by LY333334."